Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ludwig Hantson
Pharma
JPM, Day 2: Sanofi, Lilly, Takeda, Pfizer and more
It's still bright and early in San Francisco at the J.P. Morgan Healthcare Conference, but we have word on GSK launches, Amgen's Otezla and more.
Tracy Staton
,
Kyle Blankenship
Jan 14, 2020 3:00pm
Alexion chief nabs $16.5M in 2018
Mar 27, 2019 12:20pm
Could Amgen soften the biosim blow with an Alexion buy?
Jul 16, 2018 11:21am
Alexion aims for best-ever Soliris launch with newest indication
Jan 10, 2018 11:04am
Analysts peg Vertex and Alexion as stalwarts in tough 2018
Jan 2, 2018 9:28am
Activists press Alexion for stepped-up guidance, boardroom edits
Dec 8, 2017 9:53am
